Literature DB >> 4091909

Arthroscopic partial medial meniscectomy: an analysis of unsatisfactory results.

R D Ferkel, J R Davis, M J Friedman, J M Fox, W Del Pizzo, S J Snyder, C C Berasi.   

Abstract

Results of 150 arthroscopic partial medial meniscectomies were analyzed by computer to identify the factors that lead to an unsatisfactory (fair or poor) outcome. The average follow-up for the group was 36 months (range 24-60 months). One-hundred ten men and 40 women were involved, with an average age of 48 years. The overall results were 58% excellent-good, 28% fair, and 14% poor. Most tears involved the posterior horn (76%). Bucket-handle, longitudinal, and flap tears were rated 88% excellent-good, whereas horizontal cleavage and degenerative and complex tears had only 45% excellent-good scores. The results were adversely affected by the severity of the chondromalacia, work-related injury, prior knee surgery, simultaneous lateral meniscectomy, and increased knee laxity. Because degenerative posterior horn tears had such a high percentage of unsatisfactory results, the question remains as to whether all these tears need to be removed.

Entities:  

Mesh:

Year:  1985        PMID: 4091909     DOI: 10.1016/s0749-8063(85)80078-5

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  3 in total

1.  Chondral damage and age depress the long-term prognosis after partial meniscectomy. A 12- to 15-year follow-up study.

Authors:  W Maletius; K Messner
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1996       Impact factor: 4.342

2.  Future of 34 meniscectomies after bucket-handle meniscus tear: a retrospective study with a follow-up over 22 years.

Authors:  Matthias Vautrin; Claude Schwartz
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-03-03

3.  The long term outcome of open total and partial meniscectomy related to the quantity and site of the meniscus removed.

Authors:  A Hede; E Larsen; H Sandberg
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.